123 related articles for article (PubMed ID: 1361954)
1. [int-2 and c-erbB-2 gene amplification in urological cancers].
Sato K; Kato T; Moriyama M
Nihon Hinyokika Gakkai Zasshi; 1992 Dec; 83(12):1957-63. PubMed ID: 1361954
[TBL] [Abstract][Full Text] [Related]
2. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
[TBL] [Abstract][Full Text] [Related]
3. Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
Coombs LM; Pigott DA; Sweeney E; Proctor AJ; Eydmann ME; Parkinson C; Knowles MA
Br J Cancer; 1991 Apr; 63(4):601-8. PubMed ID: 1673627
[TBL] [Abstract][Full Text] [Related]
4. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification.
Habuchi T; Kinoshita H; Yamada H; Kakehi Y; Ogawa O; Wu WJ; Takahashi R; Sugiyama T; Yoshida O
J Natl Cancer Inst; 1994 Sep; 86(17):1331-5. PubMed ID: 8064891
[TBL] [Abstract][Full Text] [Related]
5. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
Somers KD; Cartwright SL; Schechter GL
Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
[TBL] [Abstract][Full Text] [Related]
6. Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables.
Suzuki H; Abo S; Kitamura M; Hashimoto M; Izumi K; Terada K; Sugiyama T
Cancer Invest; 1997; 15(5):411-5. PubMed ID: 9316622
[TBL] [Abstract][Full Text] [Related]
7. Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas.
Ikeda Y; Ozawa S; Ando N; Kitagawa Y; Ueda M; Kitajima M
Ann Thorac Surg; 1996 Sep; 62(3):835-8. PubMed ID: 8784015
[TBL] [Abstract][Full Text] [Related]
8. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas.
Tsuda T; Tahara E; Kajiyama G; Sakamoto H; Terada M; Sugimura T
Cancer Res; 1989 Oct; 49(20):5505-8. PubMed ID: 2529025
[TBL] [Abstract][Full Text] [Related]
9. c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder.
Lunec J; Challen C; Wright C; Mellon K; Neal DE
Lancet; 1992 Feb; 339(8790):439-40. PubMed ID: 1346710
[No Abstract] [Full Text] [Related]
10. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Gaffey MJ; Frierson HF; Williams ME
Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
[TBL] [Abstract][Full Text] [Related]
12. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
Champème MH; Bièche I; Hacène K; Lidereau R
Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157
[TBL] [Abstract][Full Text] [Related]
13. Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters.
Odagiri E; Kanada N; Jibiki K; Demura R; Aikawa E; Demura H
Cancer; 1994 Jun; 73(12):2978-84. PubMed ID: 7911069
[TBL] [Abstract][Full Text] [Related]
14. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
15. Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis.
Ottestad L; Andersen TI; Nesland JM; Skrede M; Tveit KM; Nustad K; Børresen AL
Acta Oncol; 1993; 32(3):289-94. PubMed ID: 8100712
[TBL] [Abstract][Full Text] [Related]
16. Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer.
Seki A; Yoshinouchi M; Seki N; Kodama J; Miyagi Y; Kudo T
Int J Oncol; 2000 Jul; 17(1):103-6. PubMed ID: 10853025
[TBL] [Abstract][Full Text] [Related]
17. [The significance of c-erbB-2 and int-2 gene alterations and DNA ploidy pattern for aggressiveness of breast cancer].
Nagayama K; Watatani M; Maeda S; Imanishi Y; Kurooka K; Wada T; Yasutomi M
Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1144-52. PubMed ID: 7901748
[TBL] [Abstract][Full Text] [Related]
18. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
Wright C; Mellon K; Johnston P; Lane DP; Harris AL; Horne CH; Neal DE
Br J Cancer; 1991 Jun; 63(6):967-70. PubMed ID: 1712624
[TBL] [Abstract][Full Text] [Related]
19. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.
Park JB; Rhim JS; Park SC; Kimm SW; Kraus MH
Cancer Res; 1989 Dec; 49(23):6605-9. PubMed ID: 2573419
[TBL] [Abstract][Full Text] [Related]
20. Gene amplifications in advanced-stage human prostate cancer.
Fournier G; Latil A; Amet Y; Abalain JH; Volant A; Mangin P; Floch HH; Lidereau R
Urol Res; 1995; 22(6):343-7. PubMed ID: 7740653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
